Clinical trial NCT01304355 - References

Irritable Bowel Syndrome — An Assessment of Cognitive Function in Irritable Bowel Syndrome

Citation(s)

•   Barbara G, Stanghellini V
  Biomarkers in IBS: when will they replace symptoms for diagnosis and management? Gut. 2009 Dec;58(12):1571-5. doi: 10.1136/gut.2008.169672. Review.
•   Barry S, Clarke G, Scully P, Dinan TG
  Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J Psychopharmacol. 2009 May;23(3):287-94. doi: 10.1177/0269881108089583. Epub 2008 Jun 18.
•   Capuron L, Lamarque D, Dantzer R, Goodall G
  Attentional and mnemonic deficits associated with infectious disease in humans. Psychol Med. 1999 Mar;29(2):291-7.
•   Capuron L, Ravaud A, Dantzer R
  Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med. 2001 May-Jun;63(3):376-86.
•   Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R
  Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002;7(5):468-73.
•   Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG
  Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol. 2009 Jan 20;9:6. doi: 10.1186/1471-230X-9-6.
•   Clarke G, Quigley EM, Cryan JF, Dinan TG
  Irritable bowel syndrome: towards biomarker identification. Trends Mol Med. 2009 Oct;15(10):478-89. doi: 10.1016/j.molmed.2009.08.001. Epub 2009 Oct 5. Review.
•   Dancey CP, Attree EA, Stuart G, Wilson C, Sonnet A
  Words fail me: the verbal IQ deficit in inflammatory bowel disease and irritable bowel syndrome. Inflamm Bowel Dis. 2009 Jun;15(6):852-7. doi: 10.1002/ibd.20837.
•   Donohoe G, Hayden J, McGlade N, O'Gráda C, Burke T, Barry S, Behan C, Dinan TG, O'Callaghan E, Gill M, Corvin AP
  Is "clinical" insight the same as "cognitive" insight in schizophrenia? J Int Neuropsychol Soc. 2009 May;15(3):471-5. doi: 10.1017/S1355617709090559.
•   Drossman DA
  The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Review.
•   Elliott R, Sahakian BJ, McKay AP, Herrod JJ, Robbins TW, Paykel ES
  Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med. 1996 Sep;26(5):975-89.
•   Ersryd A, Posserud I, Abrahamsson H, Simrén M
  Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61.
•   Fitzgerald P, Cassidy Eugene M, Clarke G, Scully P, Barry S, Quigley Eamonn MM, Shanahan F, Cryan J, Dinan Timothy G
  Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil. 2008 Dec;20(12):1291-7. doi: 10.1111/j.1365-2982.2008.01195.x. Epub 2008 Sep 24.
•   Forrest CM, Gould SR, Darlington LG, Stone TW
  Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol. 2003;527:395-400.
•   Fray PJ, Robbins TW
  CANTAB battery: proposed utility in neurotoxicology. Neurotoxicol Teratol. 1996 Jul-Aug;18(4):499-504. Review.
•   Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG, Ferrie JE
  Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009 Mar;39(3):413-23. doi: 10.1017/S0033291708003723. Epub 2008 Jun 4.
•   Kaplan JS, Erickson K, Luckenbaugh DA, Weiland-Fiedler P, Geraci M, Sahakian BJ, Charney D, Drevets WC, Neumeister A
  Differential performance on tasks of affective processing and decision-making in patients with Panic Disorder and Panic Disorder with comorbid Major Depressive Disorder. J Affect Disord. 2006 Oct;95(1-3):165-71. Epub 2006 Jun 21.
•   Kilkens TO, Honig A, Fekkes D, Brummer RJ
  The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Aliment Pharmacol Ther. 2005 Nov 1;22(9):865-74.
•   Kilkens TO, Honig A, van Nieuwenhoven MA, Riedel WJ, Brummer RJ
  Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut. 2004 Dec;53(12):1794-800.
•   Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD
  Functional GI disorders: from animal models to drug development. Gut. 2008 Mar;57(3):384-404. Epub 2007 Oct 26. Review.
•   Mayer EA
  Spinal and supraspinal modulation of visceral sensation. Gut. 2000 Dec;47 Suppl 4:iv69-72; discussion iv76. Review.
•   Michopoulos I, Zervas IM, Pantelis C, Tsaltas E, Papakosta VM, Boufidou F, Nikolaou C, Papageorgiou C, Soldatos CR, Lykouras L
  Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression. Eur Arch Psychiatry Clin Neurosci. 2008 Jun;258(4):217-25. doi: 10.1007/s00406-007-0781-8.
•   Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B
  Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007 Feb;98(1-2):143-51. Epub 2006 Sep 6.
•   O'Mahony S, Chua AS, Quigley EM, Clarke G, Shanahan F, Keeling PW, Dinan TG
  Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterol Motil. 2008 Jun;20(6):680-8. doi: 10.1111/j.1365-2982.2007.01065.x. Epub 2008 Jan 13.
•   O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG
  Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry. 2009 Feb 1;65(3):263-7. doi: 10.1016/j.biopsych.2008.06.026. Epub 2008 Aug 23.
•   Ohman L, Simrén M
  New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007 Mar;39(3):201-15. Epub 2007 Jan 30. Review.
•   Posserud I, Svedlund J, Wallin J, Simrén M
  Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease. J Psychosom Res. 2009 May;66(5):399-405. doi: 10.1016/j.jpsychores.2008.09.020. Epub 2009 Jan 8.
•   Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH
  CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry. 2010 Apr;15(4):393-403. doi: 10.1038/mp.2009.116. Epub 2009 Nov 17.
•   Rider LG, Schiffenbauer AS, Zito M, Lim KL, Ahmed A, Zemel LS, Rennebohm RM, Passo MH, Summers RM, Hicks JE, Lachenbruch PA, Heyes MP, Miller FW; Juvenile Dermatomyositis Disease Activity Collaboration Study Group
  Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies. Clin Chem. 2002 Oct;48(10):1681-8.
•   Robbins TW, Arnsten AF
  The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci. 2009;32:267-87. doi: 10.1146/annurev.neuro.051508.135535. Review.
•   Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA
  Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 2006 Aug 31;8(20):1-27. Review.
•   Schwarcz R, Pellicciari R
  Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther. 2002 Oct;303(1):1-10. Review.
•   Schwarcz R
  The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol. 2004 Feb;4(1):12-7. Review.
•   Spiller RC
  Irritable bowel syndrome. Br Med Bull. 2005 Mar 14;72:15-29. Print 2004. Review.
•   Sweeney JA, Kmiec JA, Kupfer DJ
  Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry. 2000 Oct 1;48(7):674-84.
•   Thomas M, Smith A
  An investigation into the cognitive deficits associated with chronic fatigue syndrome. Open Neurol J. 2009 Feb 27;3:13-23. doi: 10.2174/1874205X00903010013.
•   Yan E, Castillo-Meléndez M, Smythe G, Walker D
  Quinolinic acid promotes albumin deposition in Purkinje cell, astrocytic activation and lipid peroxidation in fetal brain. Neuroscience. 2005;134(3):867-75.

Kynurenine Pathway Metabolites as Novel Translational Biological Markers of Irritable Bowel Syndrome: Relationship to Gastrointestinal Function, Cognition and Co-morbid Depression

Details for clinical trial NCT01304355